Corrigendum to: Fibulin-4 as a potential extracellular vesicle marker of fibrosis in patients with cirrhosis https://doi.org/10.1002/2211-5463.13842

IF 2.8 4区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY FEBS Open Bio Pub Date : 2024-08-22 DOI:10.1002/2211-5463.13885
{"title":"Corrigendum to: Fibulin-4 as a potential extracellular vesicle marker of fibrosis in patients with cirrhosis https://doi.org/10.1002/2211-5463.13842","authors":"","doi":"10.1002/2211-5463.13885","DOIUrl":null,"url":null,"abstract":"<p>The author affiliations of the paper by Terai <i>et al</i>. [1] contains a typographical error:</p><p>2. Future Medical Research Center for Exosome and Designer Cells (F-DEC), Niigata University Japan</p><p>The correct affiliation acronym is shown below:</p><p>2. Future Medical Research Center for Exosome and Designer Cells (F-EDC), Niigata University Japan</p>","PeriodicalId":12187,"journal":{"name":"FEBS Open Bio","volume":"14 11","pages":"1927"},"PeriodicalIF":2.8000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/2211-5463.13885","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FEBS Open Bio","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/2211-5463.13885","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The author affiliations of the paper by Terai et al. [1] contains a typographical error:

2. Future Medical Research Center for Exosome and Designer Cells (F-DEC), Niigata University Japan

The correct affiliation acronym is shown below:

2. Future Medical Research Center for Exosome and Designer Cells (F-EDC), Niigata University Japan

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
更正:纤维蛋白-4 作为肝硬化患者纤维化的潜在细胞外囊泡标记物 https://doi.org/10.1002/2211-5463.13842。
Terai 等人的论文[1]中的作者单位有一处排印错误:2.日本新泻大学外泌体与设计者细胞未来医学研究中心(F-DEC)正确的作者单位缩写如下:2.日本新泻大学外泌体和设计者细胞未来医学研究中心 (F-EDC)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
FEBS Open Bio
FEBS Open Bio BIOCHEMISTRY & MOLECULAR BIOLOGY-
CiteScore
5.10
自引率
0.00%
发文量
173
审稿时长
10 weeks
期刊介绍: FEBS Open Bio is an online-only open access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal''s peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community. FEBS Open Bio is owned by the Federation of European Biochemical Societies (FEBS), a not-for-profit organization, and is published on behalf of FEBS by FEBS Press and Wiley. Any income from the journal will be used to support scientists through fellowships, courses, travel grants, prizes and other FEBS initiatives.
期刊最新文献
Issue Information HDAC4 regulates apoptosis in Acan-CreERT2;HDAC4d /d mice with osteoarthritis by downregulating ATF4. Regorafenib as a potential drug for severe COVID-19: inhibition of inflammasome activation in mice. Structural Bioinformatics: exciting times in a rapidly evolving field Pharmacological effects of osimertinib on a chicken chorioallantoic membrane xenograft model with the EGFR exon-19-deleted advanced NSCLC mutation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1